Login / Signup

A double-blind, randomised cross-over study to evaluate the absorption of a commercially available Ginkgo biloba extract compared to the liposomal extract Ginkgosome.

David BriskeyAmanda Rao
Published in: BMC complementary medicine and therapies (2022)
The novel liposomal formulation is safe in humans and demonstrates superior absorption for the supply of GBE constituents compared to a comparator standardised formulation.
Keyphrases
  • drug delivery
  • oxidative stress
  • clinical trial
  • open label
  • anti inflammatory
  • double blind